ASEGUA THERAPEUTICS LLC: Drug Recall
Recall #D-0313-2025 · 03/07/2025
Class II: Risk
Recall Details
- Recall Number
- D-0313-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- ASEGUA THERAPEUTICS LLC
- Status
- Ongoing
- Date Initiated
- 03/07/2025
- Location
- Foster City, CA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 18,541 cartons.
Reason for Recall
Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.
Product Description
Sofosbuvir and Velpatasvir, 400 mg/100 mg tablets, 28 tablets: 2x14 blister cards, Rx Only, Manufactured for: Asegua Therapeutics LLC an affiliate of Gilead Sciences, Inc., Foster City, CA 94404, Made in Ireland, NDC# 72626-2701-1
Distribution Pattern
US Nationwide
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.